Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma

NCT03843294 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma
Diffuse Large B Cell Lymphoma

Interventions

BIOLOGICAL: TAA-T cells
DRUG: Nivolumab

Sponsor

Catherine Bollard